BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 33535215)

  • 1. T2-FLAIR Mismatch Sign and Response to Radiotherapy in Diffuse Intrinsic Pontine Glioma.
    Yamasaki F; Nishibuchi I; Karakawa S; Kaichi Y; Kolakshyapati M; Takano M; Yonezawa U; Imano N; Taguchi A; Shimomura M; Taniguchi M; Onishi S; Okada S; Awai K; Sugiyama K; Nagata Y
    Pediatr Neurosurg; 2021; 56(1):1-9. PubMed ID: 33535215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of T2-FLAIR Mismatch in Nonenhancing Diffuse Gliomas Using Digital Subtraction.
    Cho NS; Sanvito F; Le VL; Oshima S; Teraishi A; Yao J; Telesca D; Raymond C; Pope WB; Nghiemphu PL; Lai A; Cloughesy TF; Salamon N; Ellingson BM
    AJNR Am J Neuroradiol; 2024 Feb; 45(2):188-197. PubMed ID: 38238098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of partial T2-FLAIR mismatch sign and isocitrate dehydrogenase mutation in WHO grade 4 gliomas: results from the ReSPOND consortium.
    Lee MD; Patel SH; Mohan S; Akbari H; Bakas S; Nasrallah MP; Calabrese E; Rudie J; Villanueva-Meyer J; LaMontagne P; Marcus DS; Colen RR; Balana C; Choi YS; Badve C; Barnholtz-Sloan JS; Sloan AE; Booth TC; Palmer JD; Dicker AP; Flanders AE; Shi W; Griffith B; Poisson LM; Chakravarti A; Mahajan A; Chang S; Orringer D; Davatzikos C; Jain R;
    Neuroradiology; 2023 Sep; 65(9):1343-1352. PubMed ID: 37468750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of T2-FLAIR discordance across a cohort of adult-type diffuse gliomas and deviations from the classic T2-FLAIR mismatch sign.
    Malik P; Soliman R; Chen YA; Munoz DG; Das S; Bharatha A; Mathur S
    Neuroradiology; 2024 Apr; 66(4):521-530. PubMed ID: 38347151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The T2-FLAIR mismatch sign in oncologic neuroradiology: History, current use, emerging data, and future directions.
    Dagher SA; Lochner RH; Ozkara BB; Schomer DF; Wintermark M; Fuller GN; Ucisik FE
    Neuroradiol J; 2023 Nov; ():19714009231212375. PubMed ID: 37924213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiparametric MRI and T2/FLAIR mismatch complements the World Health Organization 2021 classification for the diagnosis of IDH-mutant 1p/19q non-co-deleted/ATRX-mutant astrocytoma.
    Sawlani V; Jen JP; Patel M; Jain M; Haq H; Ughratdar I; Wykes V; Nagaraju S; Watts C; Pohl U
    Clin Radiol; 2024 Mar; 79(3):197-204. PubMed ID: 38101998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T2-FLAIR Mismatch: An Imaging Biomarker for Children's
    van Maren EA; Dankbaar JW; Wesseling P; Plasschaert S; Muhlebner A; Hoving EW; Robe PA; Snijders TJ; Hoogendijk R; Kranendonk MEG; Lequin MH
    AJNR Am J Neuroradiol; 2024 May; ():. PubMed ID: 38724203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal characteristics of T2-FLAIR mismatch in IDH-mutant astrocytomas: Relation to grade, histopathology, and overall survival in the GLASS-NL cohort.
    van Garderen KA; Vallentgoed WR; Lavrova A; Niers JM; de Leng WWJ; Hoogstrate Y; de Heer I; Ylstra B; van Dijk E; Klein S; Draaisma K; Robe PAJT; Verhaak RGW; Westerman BA; French PJ; van den Bent MJ; Kouwenhoven MCM; Kros JM; Wesseling P; Smits M
    Neurooncol Adv; 2023; 5(1):vdad149. PubMed ID: 38024241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncolytic DNX-2401 Virus for Pediatric Diffuse Intrinsic Pontine Glioma.
    Gállego Pérez-Larraya J; Garcia-Moure M; Labiano S; Patiño-García A; Dobbs J; Gonzalez-Huarriz M; Zalacain M; Marrodan L; Martinez-Velez N; Puigdelloses M; Laspidea V; Astigarraga I; Lopez-Ibor B; Cruz O; Oscoz Lizarbe M; Hervas-Stubbs S; Alkorta-Aranburu G; Tamayo I; Tavira B; Hernandez-Alcoceba R; Jones C; Dharmadhikari G; Ruiz-Moreno C; Stunnenberg H; Hulleman E; van der Lugt J; Idoate MÁ; Diez-Valle R; Esparragosa Vázquez I; Villalba M; de Andrea C; Núñez-Córdoba JM; Ewald B; Robbins J; Fueyo J; Gomez-Manzano C; Lang FF; Tejada S; Alonso MM
    N Engl J Med; 2022 Jun; 386(26):2471-2481. PubMed ID: 35767439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between imaging features, therapeutic response, and overall survival in pediatric diffuse intrinsic pontine glioma.
    Yu X; Lai M; Li J; Wang L; Ye K; Zhang D; Hu Q; Li S; Hu X; Wang Q; Ma M; Xiao Z; Zhou J; Shi C; Luo L; Cai L
    Neurosurg Rev; 2024 May; 47(1):212. PubMed ID: 38727935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multimodal imaging-based classification for pediatric diffuse intrinsic pontine gliomas.
    Pan C; Zhang M; Xiao X; Kong L; Wu Y; Zhao X; Sun T; Zhang P; Geng Y; Zuo P; Wang Y; Li X; Gu G; Li T; Wu Z; Zhang J; Zhang L
    Neurosurg Rev; 2023 Jun; 46(1):151. PubMed ID: 37358632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spontaneous Shrinkage of isocitrate dehydrogenase (IDH)-mutant astrocytoma caused by intra-tumoural cyst rupture: a case report.
    Suzuki R; Kanamori M; Saito R; Shimoda Y; Watanabe M; Tominaga T
    Br J Neurosurg; 2023 Feb; ():1-5. PubMed ID: 36722392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic HDAC inhibition in hypermutant diffuse intrinsic pontine glioma.
    Noll A; Myers C; Biery MC; Meechan M; Tahiri S; Rajendran A; Berens ME; Paine D; Byron S; Zhang J; Winter C; Pakiam F; Leary SES; Cole BL; Jackson ER; Dun MD; Foster JB; Evans MK; Pattwell SS; Olson JM; Vitanza NA
    Neoplasia; 2023 Sep; 43():100921. PubMed ID: 37603953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second course of re-irradiation in pediatric diffuse intrinsic pontine glioma : A case study.
    Bergengruen PM; Hernaíz Driever P; Budach V; Zips D; Grün A
    Strahlenther Onkol; 2023 Aug; 199(8):773-777. PubMed ID: 36862153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypofractionated re-irradiation for diffuse intrinsic pontine glioma.
    Mankuzhy NP; Tringale KR; Dunkel IJ; Farouk Sait S; Souweidane MM; Khakoo Y; Karajannis MA; Wolden S
    Pediatr Blood Cancer; 2024 May; 71(5):e30929. PubMed ID: 38430472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reirradiation for diffuse intrinsic pontine glioma: prognostic radiomic factors at progression.
    Wawrzuta D; Chojnacka M; Drogosiewicz M; Pędziwiatr K; Dembowska-Bagińska B
    Strahlenther Onkol; 2024 May; ():. PubMed ID: 38748214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T2-FLAIR mismatch sign predicts DNA methylation subclass and CDKN2A/B status in IDH-mutant astrocytomas.
    Lee MD; Jain R; Galbraith K; Chen A; Lieberman E; Patel SH; Placantonakis DG; Zagzag D; Barbaro M; Guillermo Prieto Eibl MDP; Golfinos JG; Orringer DA; Snuderl M
    Clin Cancer Res; 2024 Jun; ():. PubMed ID: 38829583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Model-based evaluation of image-guided fractionated whole-brain radiation therapy in pediatric diffuse intrinsic pontine glioma xenografts.
    Husband HR; Campagne O; He C; Zhu X; Bianski BM; Baker SJ; Shelat AA; Tinkle CL; Stewart CF
    CPT Pharmacometrics Syst Pharmacol; 2021 Jun; 10(6):599-610. PubMed ID: 33939327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. H3 K27-altered diffuse midline glioma in adults arising from atypical regions: Two case reports and literature review.
    Sugii N; Ninomiya Y; Akimoto Y; Tsurubuchi T; Ishikawa E
    Radiol Case Rep; 2024 Jan; 19(1):200-206. PubMed ID: 38028289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Very Long-term Survivorship in Pediatric DIPG: Case Report and Review of the Literature.
    Dimentberg E; Marceau MP; Lachance A; Bergeron-Gravel S; Saikali S; Crevier L; Bourget C; Hawkins C; Jabado N; Giannakouros P; Renzi S; Larouche V
    J Pediatr Hematol Oncol; 2024 May; 46(4):211-215. PubMed ID: 38573000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.